cancer – Page 5 – media

Mercks to Lead Squamous Lung Cancer Treatment With Keytruda

Pharma giant Merck & Co. revealed Keytruda had perfectly completed its final-stage research on the drug for previously untreated patients with skin cancer, who represent about 25% to 30% of the overall market.
- Source: Ddu
- 639
- May 24, 2018
cancer Company Insight Merck
Click-To-Release Chemotherapy – A Novel Approach

Tagworks Pharmaceuticals, based at Radboud University Medical Center, have developed a novel technique for the targeted delivery of ADCs to treat tumors. By the controlled 'click-to-release' of the chemotherapy drug from its tumor-binding carrier, the treatment would reach the right location.
- Source: Ddu
- 501
- May 23, 2018
cancer Researches
Daily Aspirin Increase Cancer Risk in Men

A research team led by Dr. Beatrice Nardone, research assistant professor of dermatology at Northwestern University Feinberg School of Medicine, discovered that daily consumption of aspirin could significantly increase the risk for melanoma (skin cancer) in men, compared to women.
- Source: Ddu
- 532
- May 22, 2018
aspirin cancer Researches
Sesen Bio Presents Bladder Cancer Treatment Data Following Name Change

The annual meeting of the American Urological Association had Sesen Bio present its three-month data for its bladder cancer treatment Vicinium. This was Sesen Bio’s first readout following its name change from Eleven Biotherapeutics.
- Source: Ddu
- 626
- May 22, 2018
bladder cancer cancer Company Insights
Accent raised $40 Million to Develop Epitranscriptomics Studies

Cambridge, Mass.-based Biotech startup Accent Therapeutics announced $40 million A series funding to develop cancer treatment based on epitranscriptomics, an RNA-modifying protein (RMPs) which have been connected to recent cancer studies.
- Source: Ddu
- 665
- May 21, 2018
biotech cancer Company Insight DNA
Breast Cancer Diagnosis Using a Pill

A research team at the University of Michigan were developing a pill which shows the presence of tumors when exposed to infrared light, and their concept worked well in mice.
- Source: Ddu
- 802
- May 21, 2018
breast cancer cancer Researches
Opt for Cancer Drug to forgo Tuberculosis

More than one-quarter of the world’s population were constantly getting affected with the one of the world’s oldest and deadliest disease named Tuberculosis (TB). In spite of 6-9 months antibiotic therapy, it’s very difficult to treat tuberculosis. That’s why researchers throughout the world were trying to find the faster ways of cure.
- Source: Ddu
- 587
- May 18, 2018
cancer Researches tuberculosis
New Blood Test for Liver Cancer Shows Promising Results

Liver cancer is the second most common cancer with a high mortality rate worldwide. According to WHO, liver cancer is the fifth most common cancer in men and seventh most common cancer in women. Treatment could be possible only if diagnosed at an early stage. Hence research studies were conducted worldwide to find the most accurate diagnostic tool to detect liver cancer.
- Source: Ddu
- 661
- May 17, 2018
cancer Researches
Amsterdam airport to be a new site for EU CAR-T manufacturing facility of Gilead

When it comes to manufacturing CAR T drugs (personalized treatments engineering immune cells to destroy cancer cells of patients) speed is of utmost importance. A new manufacturing site has been decided upon by Gilead for Yescarta, its CAR-T therapy at a Netherlands airport.
- Source: drugdu
- 667
- May 16, 2018
cancer CAR T-cells FDA New Approvals
Personalized Cancer Vaccine Looks Promising in Early Study

Researchers at the Perelman School of Medicine and the Abramson Cancer Center, at the University of Pennsylvania, developed the vaccine using dendritic cells (DCs) derived from each patient's own peripheral blood mononuclear cells. These dendritic cells were then exposed to the patient's tumor cells, activated with interferon gamma, and injected into the patient's lymph nodes.
- Source: Clinical Advisor
- 648
- May 15, 2018
anti-cancer cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.